TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-22-0332
PubMed Identifier: 36218325
Publication URI: http://europepmc.org/abstract/MED/36218325
Type: Journal Article/Review
Volume: 12
Parent Publication: Cancer discovery
Issue: 11
ISSN: 2159-8274